Nanolive label-free live cell
imaging & analysis

A revolution for cell biology

Capture dynamic, unbiased live cell data to accelerate discovery, development and therapeutics

Nanolive delivers breakthrough imaging solutions that accelerate research in growth industries such as drug discovery and cell therapy. Nanolive’s innovative solutions combine screening, imaging and analysis to radically advance how scientists study living cells and provide novel biological insights such as the mechanisms of cancer and neurodegenerative diseases.

Nanolive imaging platforms allow scientists to explore living cells in 3D without damaging them. By delivering complete measurements and understandings on a sub-cellular scale (e.g. mitochondrial networks, stem cell differentiation),  Nanolive technology allows screening across thousands of live cell populations, and potential therapeutic use of those same, unperturbed, cells.

application-fields
Application fields such as drug discovery, immuno-oncology, mitochondria & cell metabolism, neuroscience
application-fields
Groundbreaking technology (platforms & consumables)
application-fields
Swiss high precision and quality
application-fields
Over 200 units installed worldwide
application-fields
Award-winning technology
application-fields
Patented product & technology
application-fields
12’000 ft² headquarters in Switzerland with an international Team in USA & Europe
application-fields
More than 1’000 citations in scientific papers

A deep understanding of live cells and their dynamics

Our platforms, software, consumables and services are built on technology that is 100% non-invasive, thus circumventing the use of current end-point assays that damage cells.

This allows live cells to be imaged for an unlimited amount of time while characterizing their dynamics with the most reliable and quantitative results.

Our solutions are accelerating the drug discovery and development workflows of leading biopharma companies, transforming immuno-oncology, pathway discovery, mitochondrial & cell metabolism analysis, and sensitive cell line analytics. We are applying our technology to new research areas such as cell therapy manufacturing, regenerative medicine QA/QC and biotechnology.

Video: Antibodies being used as a T-cell targeting system to wipe out cancer cells

Company history

nanolive-graphic-milestones

2007-2012

Invention of Nanolive technology

Basic research at Swiss federal institute of technology Lausanne, Switzerland (EPFL)

2013

Company incorporation

Incorporation of Nanolive SA at EPFL Innovation Park, a spin-off from EPFL

2015

3D Cell Explorer

Launch of the world-first 3D label-free live cell imaging platform

2017

3D Cell Explorer-fluo

Launch of the world-first 3D live cell imaging platform combined with fluorescence

2019

CX-A

Launch of the world-first and only platform for automated 3D label-free live cell imaging for multi-well screening

2020

Business expansion

Inauguration of state-of-the-art production and research facilities in Lake Geneva Park high tech cluster

Management Team

Yann Cotte, Ph.D.

Chief Executive Officer

Learn more

Co-founder

Dr. Cotte holds a Master in Physics from the State University of New York and a PhD in Holographic Microscopy from the École Polytechnique Fédérale de Lausanne (EPFL) in Lausanne. Dr. Cotte made a fundamental discovery in microscopy during his PhD and co-founded Nanolive in 2013 where he holds since foundation the position of CEO.

Sébastien Equis, Ph.D.

Chief Technical Officer

Learn more

Co-founder

Dr. Sébastien Equis holds a Master in Optics / Physics / Electronics from Institut d’Optique in Paris and a PhD from the École Polytechnique Fédérale de Lausanne (EPFL) in Lausanne. He co-founded Nanolive in 2013 where he holds the position of CTO and is the head of product development.

Lisa Pollaro, Ph.D.

Chief Marketing Officer

Learn more

Dr. Lisa Pollaro holds a Master in Pharmaceutical Biotechnology from Padua University and a PhD in Biochemical Engineering from the École Polytechnique Fédérale de Lausanne (EPFL) in Lausanne. Dr. Pollaro manages the marketing and communication team of Nanolive.

Alexander Jones, Ph.D.

Chief Commercial Officer

Learn more

Dr. Alexander Jones is a global life science leader and manages the commercial team of Nanolive. His experience covers commercial leadership roles; driving growth in large, matrix, life-science organisations, and building out small and mid-sized organisations across EMEAI, US and APAC. He holds a PhD in Phylogenetics & Molecular Biology.

Nanolive’s Team

nanolive-company-picture

Award winning technology and products

thescientisttop10
top10
zkb-pionierpreis
wa-de-vigier-stiftung
microscopy
rd100

Receive our latest news

Register for our newsletter!